THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SOLIFENACIN SUCCINATE IN PATIENTS WITH MILD, MODERATE, AND SEVERE RENAL DISEASE

Smulders R1, Smith N2, Krauwinkel W1, Balan G3 1. Yamanouchi Europe B.V., 2. Yamanouchi Pharma America, Inc., 3. Covance, Inc.

Abstract Category

Pharmacology: Clinical

Abstract 303
Non Discussion Posters
Scientific Non Discussion Poster Session 16
Links

Abstract

28/03/2024 16:10:31